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ABSTRACT: A rapid, sensitive, and speciﬁc colorimetric
biosensor based on the use of magnetic nanoparticles (MNPs)
was designed for the detection of Pseudomonas aeruginosa in
clinical samples. The biosensing platform was based on the
measurement of P. aeruginosa proteolytic activity using a
speciﬁc protease substrate. At the N-terminus, this substrate
was covalently bound to MNPs and was linked to a gold
sensor surface via cystine at the C-terminus of the substrates.
The golden sensor appears black to naked eyes because of the
coverage of the MNPs. However, upon proteolysis, the
cleaved peptide−MNP moieties will be attracted by an
external magnet, revealing the golden color of the sensor
surface, which can be observed by the naked eye. In vitro, the
biosensor was able to detect speciﬁcally and quantitatively the presence of P. aeruginosa with a detection limit of 102 cfu/mL in
less than 1 min. The colorimetric biosensor was used to test its ability to detect in situ P. aeruginosa in clinical isolates from
patients. This biochip is anticipated to be useful as a rapid point-of-care device for the diagnosis of P. aeruginosa-related
infections.
1. INTRODUCTION
Pseudomonas aeruginosa is an opportunistic pathogen1 which is
involved in various nosocomial diseases such as respiratory
tract infections,2,3 urinary tract infections,4 wound infections,5
and bacteremia.6 P. aeruginosa was identiﬁed as the second
infectious pathogen isolated from patients with hospital-
associated pneumonia (HAP).7 Therefore, rapid and proper
diagnosis is essential to enable timely treatment in order to
reduce the risk of mortality. Accordingly, the American
Thoracic Society (ATS) and the Infectious Diseases Society
of America (IDSA) issued guidelines for the management of
HAP and emphasized on the importance of “quantitative
cultures” for speciﬁc HAP diagnosis without deleterious
consequences.8
Conventional diagnostic methods are based on culturing and
require at least 24 h to report the results, reducing the chance
of appropriate and successful treatment.3,8 Alternatively, rapid
quantitative detection methods based on real-time polymerase
chain reaction (PCR)9−11 and enzyme-linked immunosorbent
assays12 were developed to detect P. aeruginosa in HAP clinical
specimens. In these methods, results were obtained within a
few hours with high speciﬁcity and sensitivity. However, these
methods are costly and laborious and require handling by
highly skilled personnel. Bacterial enzymes, such as proteases,
are ideally suited as biomarkers for quick and sensitive
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identiﬁcation of micro-organisms in clinical samples.13 Many of
these enzymes are released into the surrounding microenviron-
ment and are accessible for detection based on sensitive
ﬂuorogenic and/or colorimetric substrates.14−17 Recently, a
speciﬁc peptide substrate was identiﬁed to detect the activity of
the P. aeruginosa speciﬁc LasA protease, of which the
expression appears to be mediated by the Las and Rhl quorum
sensing (QS) systems.13,18,19 In this study, this P. aeruginosa
speciﬁc peptide substrate was coupled to magnetic nano-
particles (MNPs) to be utilized in a rapid and speciﬁc
colorimetric biosensor.
2. RESULTS AND DISCUSSION
P. aeruginosa is considered the second most prevalent
nosocomial bacterium in hospital environments and can
contaminate medical equipment.1 Its infection is challenging
due to its resistance to a large number of antibiotics.20
Therefore, there is a high-demand for the development of
rapid and early detection method in clinical samples to guide
therapeutic treatment.
Kaman et al.13 designed and evaluated a ﬂuorogenic
substrate as a potential tool to detect the virulence of P.
aeruginosa. This P. aeruginosa speciﬁc protease substrate was
utilized in the development of the paper-based colorimetric
assay. In brief, hexanoic acid (Ahx) linkers were attached to
both terminals of the peptide sequence (Gly-Gly-Gly) to
enhance the protease accessibility to the peptide substrate near
the sensor surface. Then, a cysteine amino acid was linked to
the C-terminal, allowing the gold−thiol interaction and
resulting in the formation of a self-assembled monolayer
(SAM) of P. aeruginosa peptide−MNPs onto the gold sensor
surface. The N-terminal of the peptide was attached to the
MNPs.
2.1. Testing the P. aeruginosa Protease Biosensor.
Initially, the fabricated sensor was examined to detect the
proteolytic activity of P. aeruginosa protease by incubating 107
cfu/mL over the functionalized gold sensor surface. Upon
proteolysis, the peptide segment−MNP moiety was released
and collected by a circle shaped magnet placed at the back of
the sensor strip. This results in revealing the golden color of
the sensor surface, which is visible to the naked eye. Then, this
biosensing method was applied for quantitative detection of P.
aeruginosa. Accordingly, diﬀerent concentrations of P.
aeruginosa 4.5 × 107, 4.5 × 106, 4.5 × 105, 4.5 × 104, 4.5 ×
103, 4.5 × 102, and 4.5 × 10 cfu/mL were added over the
functionalized gold sensor. Results in Figures 1 and 2 show the
gradual increase in the visible bare gold area with increasing
bacteria concentration. This is explained by the ability of the
higher protease enzyme concentration to dissociate the
peptide−MNP moiety faster than the lower concentrations.
Moreover, to validate the colorimetric biosensor, a negative
blank [brain heart infusion (BHI) broth only] with no protease
was incubated with the sensor and showed no cleavage (Figure
2). Results conﬁrmed the ability of the fabricated biosensor to
detect P. aeruginosa.
The developed colorimetric biosensor exhibited a limit of
detection of 102 cfu/mL within one min time. This detection
limit was determined by identifying the lowest protease
concentration, capable of cleaving the covalently attached
peptide black MNP moiety, which in turn revealed the sensors’
golden surface area. The negative blank (BHI broth only)
showed no change in colors, as the sensor demonstrated no
disruption of the SAM layer (Figure 1).
This colorimetric detection method provided better
detection limit in a shorter time than the previously reported
ﬂuorescent dye including the lipid vesicle method, which was
reported by Thet et al.21 Although, their method managed to
correctly discriminate 40 clinical isolates of two pathogens, P.
aeruginosa and Staphylococcus aureus (S. aureus), their method
was used only for qualitative measurements. Another method
developed to provide quantitative detection of P. aeruginosa
was reported by Tang et al.22 This method is based on the use
of magnetic enrichment and magnetic separation methodology
and managed to detect as low as 10 cfu/mL. Dong et al.1
managed to develop a ten times more potent polymerase spiral
reaction method with a lower detection limit of 2.3 pg/μL1
within 60 min. Tang et al.23 shortened the procedure time for
DNA extraction to detection and retained a lower detection
limit of 10 cfu/mL based on magnetic enrichment and nested
PCR. All above mentioned methods are complex and require
the use of centralized labs, instrumentation, and trained
personnel. In addition, the PCR techniques are not suitable for
bed-side routine testing, unlike the colorimetric assay
described in this study which is approved to be cheap, simple,
rapid, and sensitive. Furthermore, it does not require expensive
equipment and trained personnel. It is to be mentioned that
sensor stability in addition to the amount of a substrate−MNP
composite was optimized in our previous work to achieve
optimal monolayer performance.16,17,24−26
2.2. Speciﬁcity of the Sensor. The biosensor speciﬁcity
was examined in the presence of two other pathogenic
microbes: Listeria monocytogenes (L. monocytogenes), and S.
aureus. Figure 3 shows the results of the P. aeruginosa sensors
with L. monocytogenes and S. aureus, respectively. The sensor
showed no disruption of the SAM layer and no signiﬁcant
change in the sensor surface golden color upon incubation with
Figure 1. Colorimetric P. aeruginosa proteases sensor probe tested
with diﬀerent concentrations of P. aeruginosa ranging from 4.5 × 107
to 4.5 × 10 cfu/mL.
Figure 2. Dose response of the sensor under the eﬀect of various
concentrations of P. aeruginosa.
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L. monocytogenes and S. aureus, showing suﬃcient speciﬁcity to
detect P. aeruginosa.
2.3. Detection of P. aeruginosa in Clinical Isolates.
The clinical applicability of the developed biosensors was
tested using 20 P. aeruginosa clinical isolates (among which
sputum, ear, and wound). These samples were previously
analyzed by conventional culture and PCR methods at King
Faisal Specialist Hospital microbiology laboratory. These
samples were incubated with the fabricated biosensor and all
showed positive results, with a clear cleavage of the peptide−
MNPs moiety, with a consequent appearance of the sensor
golden surface color (Figure 4). Notably, the diﬀerences in
cleavage intensity between tested samples were attributed to
the diﬀerence in the number of colonies of P. aeruginosa. A
negative control proved no cleavage of the peptide−MNPs
moiety without any disruption of the SAM layer. The
experiments were conducted in triplicate.
3. CONCLUSIONS
This study demonstrated the ability of the designed
colorimetric biosensor to detect P. aeruginosa protease in
clinical samples. The assay was simple, rapid, sensitive, and
speciﬁc and does not require any labeling or ampliﬁcation
steps. Furthermore, it does not require sample pretreatment or
preconcentration and so can be applicable for onsite use by
clinicians. This low-cost colorimetric biosensor was based on
the use of speciﬁc substrate−MNPs, which were covalently
attached to the gold sensor surface. This biosensing
conﬁguration is amenable for a qualitative and semi
quantitative detection of P. aeruginosa proteases. The limit of
detection was as low as 102 cfu/mL within one min. In
conclusion, this biosensor presented a valuable onsite
diagnostic tool to improve the control of potential risk
infections caused by P. aeruginosa.
4. MATERIALS AND METHODS
4.1. Materials and Reagents. Carboxyl-terminated beads
(50 nm diameter), N-hydroxysuccinimide (NHS), 1-(3-
dimethylaminopropyl)-3-ethyl-carbodiimide (EDC), and the
plastic pH indicator strip were purchased from Sigma-Aldrich
(Dorset, UK). Self-adhesive magnet sheets were purchased
from Polarity Magnets Company (Wickford, Essex, UK). The
P. aeruginosa peptide substrate NH2-Ahx-Gly-Gly-Gly-Ahx-Cys
was synthesized by Pepmic Co. Ltd (Suzhou, China). BHI
broth and agar were purchased from SDA, Oxoid Ltd
(Basingstoke, UK). Sterile ﬁlters (0.22 μm) were obtained
from Millipore (Watford, UK). The wash/storage buﬀer (10
mM Tris base, 150 mM sodium chloride, 0.1% (w/v) bovine
serum albumin, 1 mM ethylenediaminetetraacetic acid, 0.1%
sodium azide, pH 7.5) and the coupling buﬀer (10 mM
potassium phosphate, 0.15 M sodium chloride, pH 5.5) were
prepared from chemicals of analytical grade.
4.2. Bacteria Culture and Protease Preparation. P.
aeruginosa (ATCC 15692), S. aureus (ATCC 25923), and L.
monocytogenes (ATCC 19115) were individually cultured on
BHI agar plates for 24 h at 37 °C. Subsequently, a single
colony from each bacterium was grown in 5 mL BHI medium
and incubated at 37 °C for 16 h to provide the primary
bacterial culture (PBC) stock. Then, each bacterial concen-
tration PBC was pelted by centrifugation at 3000g for 10 min,
and the culture supernatant was ﬁltered to obtain P. aeruginosa
crude protease solution to be used later in sensitivity and
speciﬁcity studies. Also, the bacterial count was analyzed via a
spread-plate technique by plating 10-fold serial dilutions from
each bacterial concentration on BHI plates and then
incubating at 37 °C overnight.
4.3. Clinical Isolates and Protease Preparation.
Twenty clinical isolates of P. aeruginosa were collected from
King Faisal Specialist Hospital bacterial biobank in Riyadh
kingdom at Saudi Arabia. The bibliographic data of the sources
were not reviled to us. The samples were as follows: 12 from
sputum, 3 from ear, 1 from wound, and 4 from diﬀerent
(unregistered) sites. The specimens were examined in King
Faisal Specialist Hospital microbiology lab for complete
identiﬁcation and antibiotic susceptibility testing. Clinical
Figure 3. P. aeruginosa sensor speciﬁcity (A) L. monocytogenes before
and after application and (B) S. aureus before and after application.
Figure 4. Biosensing of P. aeruginosa in clinical samples from King Faisal Specialist Hospital microbiology laboratory. Sensor before (A) and after
(B) clinical sample application.
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isolates were then stored at −70 °C. After which, samples were
thawed and recultured, and a single colony from each clinical
isolate was grown in 5 mL BHI medium and incubated at 37
°C for 16 h to provide the PBC stock which was then
centrifuged to pellet bacteria. Consequently, culture super-
natant containing secreted proteases was added dropwise over
the constructed biosensor to examine its applicability.
4.4. Preparation of the Substrate−MNP Composite.
The carboxylated MNP suspension (1 mL) was mixed with the
peptide substrate (1.0 mg/mL), EDC (0.57 mg/mL) and NHS
(12 μg/mL). The mixture was shaken gently on a rotary shaker
at room temperature for 24 h. The substrate−MNP
composites were isolated using a magnet separator and washed
three times, using a washing buﬀer to remove uncoupled
components (Scheme 1A). Finally, the conjugate was
dispersed in a storage buﬀer and stored at 4 °C until further
use.24,27
4.5. Biosensing Platform Preparation and Function-
alization. Self-adhesive sheets were purchased from Whatman
(London, U.K.) and coated with gold using a sputtering
machine in the clean room at KAUST-KSA. The gold-coated
sheet was cut into rectangular pieces (4 mm × 2 mm) and
stacked over the plastic strip at a speciﬁed distance 3 mm. This
plastic strip was used as a physical support for the whole
biofunctionalization process as well as the P. aeruginosa
protease detection and quantiﬁcation sensor (Scheme 1B).
The biosensing gold surface was functionalized with a layer
of the black color substrate−MNPs composite. At the
beginning, the substrate−MNPs composite suspension was
mounted over the gold sensor surface and allowed to stand at
room temperature for 30 min for dryness (Scheme 1C).
Subsequently, an external magnet (12.5 × 12.5 × 5 mm) with a
ﬁeld strength of 3360 and 573 G at 1 and 10 mm distance,
respectively, was passed over the functionalized strip to remove
any unattached substrate−MNPs conjugates. At this stage, the
sensor surface golden color is masked and turned black
(Scheme 1C). After that, a round paper magnet was ﬁxed on
the strip back, 2−3 mm distance below the sensor platform.
4.6. Biosensing of P. aeruginosa Proteases. Culture
medium supernatant solution containing P. aeruginosa crude
proteases was added dropwise on the functionalized black
color sensor surface. During the enzymatic cleavage reaction,
the paper magnet attracted the cleaved peptide segment−
MNPs, prompting a visual observation of the sensor golden
color for a qualitative evaluation of the tested samples (Scheme
1D). Moreover, a quantitative evaluation was performed by
using diﬀerent counts of P. aeruginosa 4.5 × 107, 4.5 × 106, 4.5
× 105, 4.5 × 104, 4.5 × 103, 4.5 × 102, and 4.5 × 10 cfu/mL.
4.7. Quantitative Measurements. The images of the
sensors were taken and saved as JPEG format and processed
using the ImageJ software, which was developed by the
National Institute of Health28 to calculate the quantitative
data. The concentration was calculated by dividing the cleaved
area (yellow color) to the total black sensor area. The
quantitation was tested using diﬀerent bacteria concentrations.
Experiments were conducted in triplicate.
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